Opinion
Perth’s billionaire set is piling into this little-known medtech
The value of West Australian nerve repair biotech Orthocell has doubled since September as it beefs up its shareholder bases and prepares to break into the US.
Michael SmithHealth editorWestern Australia is better known for producing mining magnates than medical breakthroughs, but Perth-based nerve repair company Orthocell has global ambitions for its collagen patches made from Australian pigs.
As Orthocell prepares to break into the United States, the ASX-listed company is attracting some high net-worth interest.
Loading...
Michael Smith is the Health Editor for The Australian Financial Review. He is based in Sydney. Connect with Michael on Twitter. Email Michael at michael.smith@afr.com
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Healthcare & fitness
Fetching latest articles